In Royce Premier Fund, Co-Lead Portfolio Manager Steven McBoyle, Assistant Portfolio Manager Andrew Palen, and I are always looking for small-cap companies with unique business models that have high returns on capital and high reinvestment rates. In this piece, we look at a long-term holding with what we think are excellent long-term prospects.

Interparfums (IPAR) develops, distributes, and markets prestige fragrances under exclusive brand licenses and owned labels. Its expertise in creating higher end perfumes for premium or enduring brands enables its clients to monetize their brand equity outside their core product categories. Most licensing agreements have initial terms of at least 10 years, which provides Interparfums with a growing annuity stream of revenues when it is successful, while new licenses or brand acquisitions are additional sources of future growth and diversification. Jimmy Choo (17% of sales), Coach (15%), and Montblanc (15%) are the company’s three largest franchises. It has managed each for more than 10 years, and each of the brand owners negotiated early extensions of the licensing agreements as Interparfums proved its capabilities. More recently, licensed brands Lacoste and Donna Karan/DKNY (each signed in 2022) both already surpassed $100 million in revenue in 2025.

Interparfums’s strong track record of new product launches supported by robust advertising, proven global sourcing and distribution capabilities, and high-touch retail channel strategies (e.g., in-store sampling) have set it apart as one of a handful of “go to,” independent outsourcing partners for high end brands. Most prestige brand owners (non-cosmetics) that have considered or tried to build their own fragrance operations from the ground up or bring them in-house from a third party, have been dissuaded by the complexities and diseconomies of scale.

Interparfums generates almost $1.5 billion per year in revenue and typically invests 21% of sales in advertising and promotion. This marketing firepower and alignment with strong brands improves the success rate on its new launches in an industry that sees the introduction of more than 1,500 scents per year, 90% of which fail. The premium pricing associated with luxury brands, combined with an asset light business model (Interparfums has no manufacturing facilities), yields 60%+ gross margins, consistent free cash flow generation, and a long-term average return on invested capital of 35%.

Interparfums has been a solid contributor to absolute and relative return since its addition to the portfolio in 1Q20, despite a tough 2025 in which the company’s stock fell -33%. Last year’s decline in part reflected a normalization of fragrance category growth after several years of above-average (high single-digits) gains post-Covid, retailer inventory destocking, and the subpar performance of new offerings designed to recharge the growth of a few of Interparfums’s key licensed brands. Sales growth was also muted by Interparfums opting not to renew a few smaller licenses in an effort to manage the tail of its portfolio and optimize resource allocation.

Its 2026 growth plan has been primarily built around new flankers (seasonal or limited-edition fragrances) for several key brands, but without the momentum expected from certain 2025 new products (combined with an additional, intentional license exit), sales are likely to be flat for 2026. However, the company now trades at about a 9% cap rate, which we think is a compelling valuation on an absolute basis as we believe the company’s challenges are temporary, with the attractiveness and durability of the long-term business model intact.

Amid the near-term headwinds, there are a few green shoots, with some of Interparfums’s brand-specific initiatives finally gaining traction in 4Q25, while retailer order patterns appear to have stabilized with channel inventory clean. We believe the flywheel nature of its growth model should begin to reemerge in 2027 as Interparfums is slated to launch blockbusters—new fragrance families—for each of its top five brands, which accounted for 66% of 2025 sales. Interparfums has typically seen blockbusters drive 10% sales growth for a brand, net of cannibalization of existing fragrances. Even if it opts to push a few of the launches into 2028 in an effort to improve execution and return to a better balance of flankers and blockbusters in its annual launch cadence, prospects for revitalized growth should still improve significantly in 2027.

Interparfums will also be unveiling its first fragrance for Longchamp in 2027, a new license it won last year. In addition, it will also grow distribution of its own Solferino and Goutal brands, which target the niche, luxury/haute fragrance market, representing an incremental $5 billion addressable market for Interparfums.

Finally, two recently announced agreements that were competitive takeaways from Coty provide longer-term revenue visibility. Interparfums will assume responsibility for the David Beckham brand in 2028, with plans for a new signature scent in 2029, and for Nautica in 2030. Given its existing sales history, Interparfums estimates first year sales of $50 million for Beckham and $70 million for Nautica, with the expectation that Interparfums can improve their performance over time.

Important Disclosure Information